Encyclopedia of Gerontology and Population Aging

Living Edition
| Editors: Danan Gu, Matthew E. Dupre

Chronic Obstructive Pulmonary Disease (COPD)

  • Ane Arbillaga-EtxarriEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-3-319-69892-2_815-1

Definition

Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases (GOLD Update 2019).

The terms emphysema and chronic bronchitis (Medical Research Council Committee on the Aetiology of Chronic Bronchitis 1965) are commonly incorrectly used in defining COPD. Emphysema is a destruction of the alveolus, which are the gas-exchanging surfaces of the lung (also called parenchyma). This pathological term is often used clinically; however, it describes only one of several structural abnormalities present in COPD. On the other hand, chronic bronchitis is defined as the presence of cough and sputum production for at least 3 months in each of two consecutive years (Medical Research Council Committee on the Aetiology of Chronic Bronchitis). This is a clinically and...

This is a preview of subscription content, log in to check access.

References

  1. Akinbami LJ, Liu X (2011) Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009. NCHS Data Brief 63:1–8Google Scholar
  2. Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA (2016) The presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease development. Am J Respir Crit Care Med 193(6):662–672.  https://doi.org/10.1164/rccm.201511-2210OCCrossRefGoogle Scholar
  3. Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Benet M, Borrell E et al (2018) Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial. Eur Respir J.  https://doi.org/10.1183/13993003.00063-2018CrossRefGoogle Scholar
  4. Barnes PJ (2016) Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 138(1):16–27.  https://doi.org/10.1016/j.jaci.2016.05.011CrossRefGoogle Scholar
  5. Bauman AE, Reis RS, Sallis JF et al (2012) Correlates of physical activity: why are some people physically active and others not? Lancet 380:258–271.  https://doi.org/10.1016/S0140-6736(12)60735-1CrossRefGoogle Scholar
  6. Bellia V, Pistelli R, Catalano F et al (2000) Quality control of spirometry in the elderly. The SA.R.A. study. Salute Respiration nell’Anziano = Respiratory Health in the Elderly. Am J Respir Crit Care Med 161:1094–1100CrossRefGoogle Scholar
  7. Beran D, Zar HJ, Perrin C, Menezes AM, Burney P (2015) Forum of International Respiratory Societies working group c. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med 3:159–170.  https://doi.org/10.1016/S2213-2600(15)00004-1CrossRefGoogle Scholar
  8. Blackstock FC, ZuWallack R, Nici L, Lareau SC (2016) Why don’t our patients with chronic obstructive pulmonary disease listen to us? The enigma of nonadherence. Ann Am Thorac Soc 13(3):317–323.  https://doi.org/10.1513/AnnalsATS.201509-600PSCrossRefGoogle Scholar
  9. Bozier J, Rutting S, Xenaki D, Peters M, Adcock I, Oliver BG (2019) Heightened response to e-cigarettes in COPD. ERJ Open Res 5:00192-2018.  https://doi.org/10.1183/23120541.00192-2018CrossRefGoogle Scholar
  10. Buist AS, McBurnie MA, Vollmer WM et al (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370(9589):741–750CrossRefGoogle Scholar
  11. Chang S, Lee TH (2018) Beyond evidence-based medicine. N Engl J Med 379:1983–1985.  https://doi.org/10.1056/NEJMp1806984CrossRefGoogle Scholar
  12. Cho SH, Lin HC, Ghoshal AG et al (2016) Respiratory disease in the Asia-Pacific region: cough as a key symptom. Allergy Asthma Proc 37(2):131–140.  https://doi.org/10.2500/aap.2016.37.3925CrossRefGoogle Scholar
  13. Cranston JM, Crockett AJ, Moss JR, Alpers JH (2005) Domiciliary oxygen for chronicobstructive pulmonary disease. Cochrane Database Syst Rev 4:CD001744.  https://doi.org/10.1002/14651858.CD001744.pub2CrossRefGoogle Scholar
  14. Desveaux L, Janaudis-Ferreira T, Goldstein R, Brooks D (2015) An international comparison of pulmonary rehabilitation: a systematic review. COPD 12:144–153.  https://doi.org/10.3109/15412555.2014.922066CrossRefGoogle Scholar
  15. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J (2006) Assessment of the economic burden of COPD in the US: a review and synthesis of the literature. COPD 3(4):211–218CrossRefGoogle Scholar
  16. Gimeno-Santos E, Frei A, Steurer-Stey C et al (2014) Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 69:731–739.  https://doi.org/10.1136/thoraxjnl-2013-204763CrossRefGoogle Scholar
  17. GOLD Update (2019) Global strategy for prevention, diagnosis and management of COPD. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.6-FINAL-08Nov2018-wms.pdf
  18. Guerra S, Stern DA, Zhou M et al (2013) Combined effects of parental and active smoking on early lung function deficits: a prospective study from birth to age 26 years. Thorax 68(11):1021–1028.  https://doi.org/10.1136/thoraxjnl-2013-203538CrossRefGoogle Scholar
  19. Hayton C, Clark A, Olive S et al (2013) Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med 107(3):401–407.  https://doi.org/10.1016/j.rmed.2012.11.016CrossRefGoogle Scholar
  20. Hogg JC, Paré PD, Hackett TL (2017) The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev 97(2):529–552.  https://doi.org/10.1152/physrev.00025.2015CrossRefGoogle Scholar
  21. Holland AE, Mahal A, Hill CJ et al (2017) Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax 72(1):57–65.  https://doi.org/10.1136/thoraxjnl-2016-208514CrossRefGoogle Scholar
  22. Jones JH, Zelt JT, Hirai DM, Diniz CV, Zaza A, O’Donnell DE, Neder JA (2017) Emphysema on thoracic CT and exercise ventilatory inefficiency in mild-to-moderate COPD. COPD 14(2):210–218.  https://doi.org/10.1080/15412555.2016.1253670CrossRefGoogle Scholar
  23. Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC (2012) Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol 68(10):1365–1373.  https://doi.org/10.1007/s00228-012-1279-5CrossRefGoogle Scholar
  24. Lacasse Y, Cates CJ, McCarthy B, Welsh EJ (2015) This Cochrane Review is closed: deciding what constitutes enough research and where next for pulmonary rehabilitation in COPD. Cochrane Database Syst Rev 11:ED000107.  https://doi.org/10.1002/14651858.ED000107.CrossRefGoogle Scholar
  25. Lahham A, McDonald CF, Holland AE (2016) Exercise training alone or with the addition of activity counseling improves physical activity levels in COPD: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis 11:3121CrossRefGoogle Scholar
  26. Lange P, Celli B, Agusti A et al (2015) Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 373(2):111–122.  https://doi.org/10.1056/NEJMoa1411532CrossRefGoogle Scholar
  27. Long-Term Oxygen Treatment Trial Research Group (2016) A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med 375(17):1617–1627.  https://doi.org/10.1056/NEJMoa1604344CrossRefGoogle Scholar
  28. Lozano R et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128.  https://doi.org/10.1016/S0140-6736(12)61728-0CrossRefGoogle Scholar
  29. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K (2003) Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 97(2):11CrossRefGoogle Scholar
  30. Mantoani LC, Rubio N, McKinstry B, MacNee W, Rabinovich RA (2016) Interventions to modify physical activity in patients with COPD: a systematic review. Eur Respir J 48(1):69–81.  https://doi.org/10.1183/13993003.01744-2015CrossRefGoogle Scholar
  31. Medical Research Council Committee on the Aetiology of Chronic Bronchitis (1965) Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1(7389):775–779Google Scholar
  32. Miller J, Edwards LD, Agusti A et al (2013) Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 107(9):1376–1384.  https://doi.org/10.1016/j.rmed.2013.05.001CrossRefGoogle Scholar
  33. Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868.  https://doi.org/10.1136/thx.2009.115725CrossRefGoogle Scholar
  34. Miravitlles M, Worth H, Soler Cataluna JJ et al (2014) Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res 15:122.  https://doi.org/10.1186/s12931-014-0122-1.CrossRefGoogle Scholar
  35. Oates GR, Hamby BW, Stepanikova I, Knight SJ, Bhatt SP, Hitchcock J, Schumann C, Dransfield MT (2017) Social determinants of adherence to pulmonary rehabilitation for chronic obstructive pulmonary disease. COPD 14(6):610–617.  https://doi.org/10.1080/15412555.2017CrossRefGoogle Scholar
  36. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497CrossRefGoogle Scholar
  37. Raju S, Keet CA, Paulin LM et al (2019) Rural residence and poverty are independent risk factors for COPD in the United States. Am J Respir Crit Care Med 199(8):961–969.  https://doi.org/10.1164/rccm.201807-1374OCCrossRefGoogle Scholar
  38. Rand CS (2005) Patient adherence with COPD therapy. Eur Respir Rev 14(96):97–101.  https://doi.org/10.1183/09059180.05.00009604CrossRefGoogle Scholar
  39. Rochester CL, Vogiatzis I, Holland AE et al (2015) An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med 192:1373–1386.  https://doi.org/10.1164/rccm.201510-1966STCrossRefGoogle Scholar
  40. Singh S (2016) One step at a time. Lifestyle physical activity interventions. Ann Am Thorac Soc 13:586–587.  https://doi.org/10.1513/AnnalsATS.201601-039EDCrossRefGoogle Scholar
  41. Soler N, Esperatti M, Ewig S, Huerta A, Agusti C, Torres A (2012) Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur Respir J 40(6):1344–1353.  https://doi.org/10.1183/09031936.00150211CrossRefGoogle Scholar
  42. Soriano JB, Rodriguez-Roisin R (2011) Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc 8(4):363–367.  https://doi.org/10.1513/pats.201102-017RMCrossRefGoogle Scholar
  43. Spruit MA, Singh SJ, Garvey C et al (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188(8):e13–e64.  https://doi.org/10.1164/rccm.201309-1634ST.CrossRefGoogle Scholar
  44. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T (2013) Physician advice for smoking cessation. Cochrane Database Syst Rev 5(5):CD000165.  https://doi.org/10.1002/14651858.CD000165.pub4.CrossRefGoogle Scholar
  45. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T (2016) Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 3:CD008286.  https://doi.org/10.1002/14651858.CD008286.pub3.CrossRefGoogle Scholar
  46. Steiner M, McMillan V, Lowe D, et al (2018) Pulmonary rehabilitation: an exercise in improvement. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: clinical and organisational audits of pulmonary rehabilitation services in England and Wales 2017Google Scholar
  47. Townend J, Minelli C, Mortimer K et al (2017) The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J 49(6).  https://doi.org/10.1183/13993003.01880-2016CrossRefGoogle Scholar
  48. Vogiatzis I, Rochester CL, Spruit MA, Troosters T, Clini EM (2016) American Thoracic Society/European Respiratory Society Task Force on Policy in Pulmonary Rehabilitation. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J 47(5):1336–1341.  https://doi.org/10.1183/13993003.02151-2015.CrossRefGoogle Scholar
  49. Vorrink SN, Kort HS, Troosters T et al (2011) Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res 12:33.  https://doi.org/10.1186/1465-9921-12-33CrossRefGoogle Scholar
  50. Waatevik M, Skorge TD, Omenaas E et al (2013) Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med 107:1037–1045.  https://doi.org/10.1016/j.rmed.2013.04.008CrossRefGoogle Scholar
  51. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH (2007) Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 4(8):626–34CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Physical Activity and Sports Sciences, Faculty of Psychology and EducationUniversity of DeustoDonostia-San SebastiánSpain

Section editors and affiliations

  • Mari Armstrong-Hough
    • 1
  1. 1.Laboratory of Epidemiology and Public Health, School of Public HealthYale UniversityNew HavenUSA